Article

Smokers appear to have greater risk and faster progression of AMD

Smokers have an increased long-term risk and greater progression of age-related macular degeneration (AMD).

Beaver Dam, WI-Smokers have an increased long-term risk and greater progression of age-related macular degeneration (AMD), according to a study in the January issue of Archives of Ophthalmology.

Smoking had already been identified as one of the risk factors for AMD, according to the study. Smoking may contribute to AMD by reducing antioxidant levels, decreasing blood flow around the eye, or affecting the pigments in the retina.

Ronald Klein, MD, MPH, and colleagues at the University of Wisconsin School of Medicine and Public Health, Madison, studied 4,926 residents of Beaver Dam, WI, who were ages 43 to 84 years in 1987 to 1988. They were initially examined in 1988 to 1990 and were re-examined every 5 years for the next 15 years.

At the beginning of the study, 21% of the men and 18% of the women in the study were smokers. Smokers had a 47% increase in their odds of developing early AMD. Smokers also developed AMD at a younger age (69.2 years) than former smokers (72.3 years) and those who had never smoked (74.4 years).

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.